<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Int AIDS Soc</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Int AIDS Soc</journal-id>
      <journal-id journal-id-type="publisher-id">JIAS</journal-id>
      <journal-title-group>
        <journal-title>Journal of the International AIDS Society</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1758-2652</issn>
      <publisher>
        <publisher-name>International AIDS Society</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27802846</article-id>
      <article-id pub-id-type="pmc">5090107</article-id>
      <article-id pub-id-type="publisher-id">20966</article-id>
      <article-id pub-id-type="doi">10.7448/IAS.19.1.20966</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Short Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Declining trend in transmitted drug resistance detected in a prospective cohort study of acute HIV infection in Bangkok, Thailand</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Colby</surname>
            <given-names>Donn J</given-names>
          </name>
          <xref ref-type="corresp" rid="cor1">&#xA7;</xref>
          <xref ref-type="aff" rid="AF0001">1</xref>
          <xref ref-type="aff" rid="AF0002">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Crowell</surname>
            <given-names>Trevor A</given-names>
          </name>
          <xref ref-type="aff" rid="AF0003">3</xref>
          <xref ref-type="aff" rid="AF0004">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sirivichayakul</surname>
            <given-names>Sunee</given-names>
          </name>
          <xref ref-type="aff" rid="AF0002">2</xref>
          <xref ref-type="aff" rid="AF0005">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pinyakorn</surname>
            <given-names>Suteeraporn</given-names>
          </name>
          <xref ref-type="aff" rid="AF0003">3</xref>
          <xref ref-type="aff" rid="AF0004">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kroon</surname>
            <given-names>Eugene</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
          <xref ref-type="aff" rid="AF0002">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Benjapornpong</surname>
            <given-names>Khunthalee</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
          <xref ref-type="aff" rid="AF0002">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Intasan</surname>
            <given-names>Jintana</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
          <xref ref-type="aff" rid="AF0002">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Trichavaroj</surname>
            <given-names>Rapee</given-names>
          </name>
          <xref ref-type="aff" rid="AF0006">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tovanabutra</surname>
            <given-names>Sodsai</given-names>
          </name>
          <xref ref-type="aff" rid="AF0004">4</xref>
          <xref ref-type="aff" rid="AF0005">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Robb</surname>
            <given-names>Merlin</given-names>
          </name>
          <xref ref-type="aff" rid="AF0003">3</xref>
          <xref ref-type="aff" rid="AF0004">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Phanuphak</surname>
            <given-names>Praphan</given-names>
          </name>
          <xref ref-type="aff" rid="AF0002">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ananworanich</surname>
            <given-names>Jintanat</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
          <xref ref-type="aff" rid="AF0003">3</xref>
          <xref ref-type="aff" rid="AF0004">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Phanuphak</surname>
            <given-names>Nittaya</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
          <xref ref-type="aff" rid="AF0002">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <collab>on behalf of the Search 010/RV 254 Study Group</collab>
        </contrib>
      </contrib-group>
      <aff id="AF0001"><label>1</label>SEARCH-Thailand, Bangkok, Thailand</aff>
      <aff id="AF0002"><label>2</label>The Thai Red Cross AIDS Research Centre, Bangkok, Thailand</aff>
      <aff id="AF0003"><label>3</label>U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA</aff>
      <aff id="AF0004"><label>4</label>Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA</aff>
      <aff id="AF0005"><label>5</label>Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand</aff>
      <aff id="AF0006"><label>6</label>Department of Retrovirology, Armed Forces Research Institute of Medical Sciences &#x2013; US Component, Bangkok, Thailand</aff>
      <author-notes>
        <corresp id="cor1"><label>&#xA7;</label><bold>Corresponding author:</bold> Donn J Colby, SEARCH, Thai Red Cross AIDS Research Centre, 104 Ratchadamri Road, Pathumwan, Bangkok 10330, Thailand. Tel: +66 2254 2566. (<email xlink:href="donn.c@searchthailand.org">donn.c@searchthailand.org</email>)
</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>31</day>
        <month>10</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>19</volume>
      <issue>1</issue>
      <elocation-id content-type="doi">20966</elocation-id>
      <history>
        <date date-type="received">
          <day>13</day>
          <month>2</month>
          <year>2016</year>
        </date>
        <date date-type="rev-recd">
          <day>18</day>
          <month>7</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>22</day>
          <month>8</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2016 Colby DJ et al; licensee International AIDS Society</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution 3.0 Unported (CC BY 3.0) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <sec id="st1">
          <title>Introduction</title>
          <p>As availability of antiretroviral therapy expands in developing countries, the risk for transmission of drug-resistant HIV also increases. Patients with acute HIV infection (AHI) provide an opportunity for real-time monitoring of transmitted drug resistance (TDR). SEARCH 010/RV 254 study is a prospective, longitudinal study of AHI. This analysis was performed to characterize changes in TDR over time in persons enrolled in the AHI cohort.</p>
        </sec>
        <sec id="st2">
          <title>Methods</title>
          <p>Genotype testing for TDR mutations was performed on 229 subjects enrolled from 2009 to 2014.</p>
        </sec>
        <sec id="st3">
          <title>Results</title>
          <p>The cohort was predominantly male (95%) and men who have sex with men (92%). TDR prevalence was 7.0%, declining from 12.5% in 2009&#x2013;2010 to 4.8% in 2013&#x2013;2014 (<italic>p</italic>=0.08). By drug class, resistance prevalence was 3.6% for proteases inhibitors, 2.6% for nucleoside/nucleotide reverse transcriptase inhibitors and 2.2% for non-nucleoside reverse transcriptase inhibitors. The greatest decline in prevalence was seen in the non-nucleoside reverses transcriptase inhibitors, from 9.4% in 2009&#x2013;2010 to 0.7% in 2013&#x2013;2014 (<italic>p</italic>=0.005).</p>
        </sec>
        <sec id="st4">
          <title>Conclusions</title>
          <p>TDR appears to be declining among individuals with AHI in Bangkok and in 2013 to 2014 met the World Health Organization definition for low prevalence. Continued surveillance is necessary to determine if this trend persists.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>transmitted drug resistance</kwd>
        <kwd>acute HIV infection</kwd>
        <kwd>men who have sex with men</kwd>
        <kwd>Thailand</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="S0001">
      <title>Introduction</title>
      <p>Men who have sex with men (MSM) are the largest single group acquiring new HIV infections in Thailand, accounting for over 40% of new infections in 2013 [<xref rid="CIT0001" ref-type="bibr">1</xref>]. Despite an overall decrease in new HIV infections each year, and decreasing incidence among heterosexuals and people who inject drugs, the annual number of new HIV infections among MSM in Thailand continues to rise [<xref rid="CIT0002" ref-type="bibr">2</xref>]. For the past decade, the HIV prevalence among MSM in Bangkok has remained 20 to 30% [<xref rid="CIT0003" ref-type="bibr">3</xref>], and HIV incidence was consistently above 5 per 100 person-years [<xref rid="CIT0004" ref-type="bibr">4</xref>&#x2013;<xref rid="CIT0006" ref-type="bibr">6</xref>]. At the Thai Red Cross Anonymous Clinic, the largest HIV testing centre in the country, 92% of acute HIV infections (AHI) identified are in MSM [<xref rid="CIT0007" ref-type="bibr">7</xref>].</p>
      <p>AHI presents the most opportune time to test for transmitted drug resistance (TDR). Previous research has shown that TDR is found at higher prevalence during AHI than in chronically infected patients [<xref rid="CIT0008" ref-type="bibr">8</xref>], and that resistance mutations detected early in HIV infection may eventually become undetectable in the absence of selective pressure from antiretroviral therapy (ART) [<xref rid="CIT0009" ref-type="bibr">9</xref>,<xref rid="CIT0010" ref-type="bibr">10</xref>]. Such archived but undetectable mutations can lead to early treatment failure after initiation of ART [<xref rid="CIT0011" ref-type="bibr">11</xref>,<xref rid="CIT0012" ref-type="bibr">12</xref>].</p>
      <p>TDR prevalence varies greatly by geographic region and population studied. A recent meta-analysis reported 2.9% TDR overall in South and Southeast Asia with no significant trend over time [<xref rid="CIT0013" ref-type="bibr">13</xref>]. By comparison, TDR prevalence was 9.4% in Europe and 11.5% in North America. In Bangkok, TDR has been reported at 4.0 to 4.9% [<xref rid="CIT0014" ref-type="bibr">14</xref>,<xref rid="CIT0015" ref-type="bibr">15</xref>]. Among Chinese MSM across 19 provinces, TDR was 4.9% [<xref rid="CIT0016" ref-type="bibr">16</xref>]. Cohorts with a majority of MSM in the high-income countries of Japan and Taiwan reported TDR prevalence of 9.1 and 11.1%, respectively [<xref rid="CIT0017" ref-type="bibr">17</xref>,<xref rid="CIT0018" ref-type="bibr">18</xref>]. The World Health Organization (WHO) classifies the level of TDR as low (&lt;5%), moderate (5&#x2013;15%) and high (&gt;15%) [<xref rid="CIT0019" ref-type="bibr">19</xref>].</p>
      <p>We have previously reported a 9.2% prevalence of TDR in a Thai cohort that comprised primarily of MSM with AHI [<xref rid="CIT0020" ref-type="bibr">20</xref>]. In this analysis, we report on longitudinal data from the same cohort and assess the change in TDR prevalence over time.</p>
    </sec>
    <sec sec-type="methods" id="S0002">
      <title>Methods</title>
      <p>The SEARCH 010/RV 254 study (clinicaltrials.gov NCT00796146) is an ongoing prospective, a longitudinal cohort study of participants with AHI in Bangkok and Pattaya, Thailand. The methods for identifying and enrolling individuals with protocol-defined AHI have been described previously [<xref rid="CIT0007" ref-type="bibr">7</xref>,<xref rid="CIT0021" ref-type="bibr">21</xref>]. Briefly, subjects are identified with AHI at selected HIV testing centres if they have a non-reactive fourth generation (4thG) enzyme immunoassay (EIA) detecting HIV antigen and HIV antibodies and positive HIV nucleic acid testing (NAT), or a reactive 4thG EIA and are non-reactive on a less sensitive second generation (2ndG) EIA detecting only anti-HIV IgG. Subjects are staged according to the published 4thG AHI staging system: stage 1 (NAT+, 4thG EIA-, third generation [3rdG] EIA-), stage 2 (NAT+, 4thG EIA+, 3rdG EIA-) and stage 3 (NAT+, 4thG EIA+, 3rdG EIA+, Western Blot- or indeterminate) [<xref rid="CIT0021" ref-type="bibr">21</xref>]. Subjects presenting for HIV screening between 20 April 2009 and 31 December 2014 were included in this analysis. All subjects in the cohort were offered ART regardless of CD4 count using drug regimens recommended in the Thai National HIV Treatment guidelines [<xref rid="CIT0022" ref-type="bibr">22</xref>]. ART regimens were adjusted if any resistance mutations were discovered on genotype testing. All subjects provided written informed consent to participate in the study. The study protocol was approved by the institutional review boards of Chulalongkorn University, Bangkok, Thailand, and the Walter Reed Army Institute of Research, Silver Spring, MD, USA.</p>
      <sec id="S0002-S20001">
        <title>HIV genotyping</title>
        <p>HIV genotyping was performed to detect mutations in the reverse transcriptase (RT) and protease (PR) genes at the time of enrolment into the cohort, before the initiation of ART. The TRUGENE HIV-1 genotyping assay (Siemens Healthcare Diagnostics, Bayswater, Victoria, Australia) was used for the first 66 samples, and a validated in-house method was used for the remaining samples [<xref rid="CIT0023" ref-type="bibr">23</xref>]. Genotype sequences were analyzed using the Stanford University Drug Resistance Database [<xref rid="CIT0024" ref-type="bibr">24</xref>,<xref rid="CIT0025" ref-type="bibr">25</xref>], and mutations were categorized according to the WHO surveillance drug resistance mutation (SDRM) list [<xref rid="CIT0026" ref-type="bibr">26</xref>]. Each mutation was classified as conferring resistance to nucleoside and nucleotide analogue reverse transcriptase inhibitors (NRTI), non-nucleoside analogue reverse transcriptase inhibitors (NNRTI) or protease inhibitors (PI). HIV subtype was screened using the multiregion hybridization assay (MHAbce) [<xref rid="CIT0027" ref-type="bibr">27</xref>] for the first 63 samples and HIVSeq [<xref rid="CIT0028" ref-type="bibr">28</xref>,<xref rid="CIT0029" ref-type="bibr">29</xref>] for the remaining samples. HIV-1 subtype was determined using NCBI Genotyping tool (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/genotyping/formpage.cgi">www.ncbi.nlm.nih.gov/projects/genotyping/formpage.cgi</ext-link>) and jpHMM tool (<ext-link ext-link-type="uri" xlink:href="http://jphmm.gobics.de">www.jphmm.gobics.de</ext-link>). Molecular Evolutionary Genetics Analysis (MEGA) 5.0 was used to construct a maximum likelihood tree of the sequences from this study and reference HIV-1 subtype strains to further confirm genetic subtypes.</p>
      </sec>
      <sec id="S0002-S20002">
        <title>Statistical analysis</title>
        <p>Prevalence of TDR was calculated by dividing the number of subjects with detectable SDRM by the total number of subjects with available genotyping data. Ninety-five percent confidence intervals (CIs) were calculated using the Clopper-Pearson interval. Trend over time was assessed using the Chi-squared test for trend. Because of the small number of subjects enrolled annually early in the study, data were analyzed using two-year intervals from 2009 to 2014. All analyses were performed using Stata Statistical Software Release 13 (Stata Corp, College Station, TX, USA). Significance was set at alpha equal to 0.05, and all <italic>p</italic>-values are two-sided.</p>
      </sec>
    </sec>
    <sec sec-type="results" id="S0003">
      <title>Results</title>
      <p>From April 2009 to December 2014, the study enrolled 233 subjects with AHI. Genotype test results were available for 229 subjects, of whom 228 had successful sequencing of the RT gene and 225 had sequencing of the PR gene. Two subjects did not have adequate sample for genotype testing, and two samples failed to amplify. Characteristics of the study population are reported in <xref ref-type="table" rid="T0001">Table 1</xref>. Median age was 28 years, 95% were male and 92% were MSM. The median time from HIV exposure to study entry was 18 days. Median HIV RNA viral load was 5.8 log<sub>10</sub>copies/ml. The most common HIV subtype was CRF01_AE (80.6%). Results of fourth generation staging are shown in <xref ref-type="table" rid="T0001">Table 1</xref>, with no significant change in stage at enrolment over time (data not shown).</p>
      <table-wrap id="T0001" position="float">
        <label>Table 1</label>
        <caption>
          <p>Characteristics of the population with acute HIV infection in Bangkok, Thailand</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th align="left" rowspan="1" colspan="1">Characteristics</th>
              <th align="center" rowspan="1" colspan="1">(<italic>n</italic>=229)</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">Age, years, median (IQR)</td>
              <td align="center" rowspan="1" colspan="1">28 (23&#x2013;32)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Male, <italic>n</italic> (%)</td>
              <td align="center" rowspan="1" colspan="1">218 (95)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Sexual orientation, <italic>n</italic> (%)</td>
              <td align="center" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">&#x2003;MSM</td>
              <td align="center" rowspan="1" colspan="1">212 (93)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">&#x2003;Heterosexual male</td>
              <td align="center" rowspan="1" colspan="1">6 (2)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">&#x2003;Heterosexual female</td>
              <td align="center" rowspan="1" colspan="1">11 (5)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Duration since history of HIV exposure, median (IQR) days</td>
              <td align="center" rowspan="1" colspan="1">18 (14&#x2013;24)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Sexual partners in the past 30 days, median (range)</td>
              <td align="center" rowspan="1" colspan="1">2 (1&#x2013;20)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Recreational drug use in the past 30 days, <italic>n</italic> (%)</td>
              <td align="center" rowspan="1" colspan="1">51 (22)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">4th G staging</td>
              <td align="center" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">&#x2003;Stage 1 (NAT+, 4thG EIA&#x2212;, 3rdG EIA &#x2212;)</td>
              <td align="center" rowspan="1" colspan="1">31 (14)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">&#x2003;Stage 2 (NAT+, 4thG EIA+, 3rdG EIA &#x2212;)</td>
              <td align="center" rowspan="1" colspan="1">71 (31)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">&#x2003;Stage 3 (NAT+, 4thG EIA+, 3rdG EIA+, WB&#x2013;/indeterminate)</td>
              <td align="center" rowspan="1" colspan="1">127 (55)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">HIV RNA (log10 copies/mL), Median (IQR)</td>
              <td align="center" rowspan="1" colspan="1">5.8 (5.2&#x2013;6.8)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">CD4 (cells/mm<sup>3</sup>), Median (IQR)</td>
              <td align="center" rowspan="1" colspan="1">354 (265&#x2013;490)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Subtype</td>
              <td align="center" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">&#x2003;CRF01_AE</td>
              <td align="center" rowspan="1" colspan="1">183 (80.6)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">&#x2003;B</td>
              <td align="center" rowspan="1" colspan="1">10 (4.4)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">&#x2003;C</td>
              <td align="center" rowspan="1" colspan="1">1 (0.4)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">&#x2003;01AE/B</td>
              <td align="center" rowspan="1" colspan="1">25 (11.0)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">&#x2003;01AE/B/C</td>
              <td align="center" rowspan="1" colspan="1">1 (0.4)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">&#x2003;01AE/02AG</td>
              <td align="center" rowspan="1" colspan="1">1 (0.4)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">&#x2003;Non-typable</td>
              <td align="center" rowspan="1" colspan="1">6 (2.6)</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn>
            <p>IQR, inter-quartile range; MSM, men who have sex with men; NAT, nucleic acid testing; EIA, enzyme immunoassay; WB, western blot.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>Mutations from the WHO SDRM list were identified in 16 subjects for an overall TDR prevalence in the cohort of 7.0% (95% CI: 4.0&#x2013;11.1%) (<xref ref-type="table" rid="T0002">Table 2</xref>). Prevalence of resistance by drug class was highest for the PI drugs at 3.6% (1.5&#x2013;6.9%), followed by NRTI 2.6% (1.0&#x2013;5.6%) and NNRTI 2.2% (0.7&#x2013;5.0%). TDR prevalence declined from 12.5% in 2009&#x2013;2010 to 4.8% in 2013&#x2013;2014 (<xref ref-type="fig" rid="F0001">Figure 1</xref>), although the trend was not statistically significant (<italic>p</italic>=0.08). There was a significant decline in resistance to NNRTI from 9.4% in 2009&#x2013;2010 to 0.7% in 2013&#x2013;2014 (<italic>p</italic>=0.01). NRTI resistance demonstrated a non-significant decline from 6.3 to 1.4% (<italic>p</italic>=0.09), whereas resistance to PI had no discernible trend over time (<italic>p</italic>=0.64).</p>
      <fig id="F0001" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Change over time in surveillance drug resistance mutation (SDRM) prevalence among patients with acute HIV infection in Bangkok, Thailand (<italic>n</italic>=229). Bars represent prevalence by drug class; the line represents the total prevalence for SDRM in the cohort.</p>
        </caption>
        <graphic xlink:href="JIAS-19-20966-g001"/>
      </fig>
      <table-wrap id="T0002" position="float">
        <label>Table 2</label>
        <caption>
          <p>SDRM prevalence by year</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th align="left" rowspan="1" colspan="1"/>
              <th align="center" rowspan="1" colspan="1">Overall</th>
              <th align="center" rowspan="1" colspan="1">2009&#x2013;2010</th>
              <th align="center" rowspan="1" colspan="1">2011&#x2013;2012</th>
              <th align="center" rowspan="1" colspan="1">2013&#x2013;2014</th>
              <th align="center" rowspan="1" colspan="1">
<italic>p</italic>
</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">
<italic>N</italic> enrolled</td>
              <td align="center" rowspan="1" colspan="1">229</td>
              <td align="center" rowspan="1" colspan="1">32</td>
              <td align="center" rowspan="1" colspan="1">52</td>
              <td align="center" rowspan="1" colspan="1">145</td>
              <td align="center" rowspan="1" colspan="1">&#x2013;</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Any resistance, <italic>n</italic> (%)</td>
              <td align="center" rowspan="1" colspan="1">16 (7.0)</td>
              <td align="center" rowspan="1" colspan="1">4 (12.5)</td>
              <td align="center" rowspan="1" colspan="1">5 (9.6)</td>
              <td align="center" rowspan="1" colspan="1">7 (4.8)</td>
              <td align="center" rowspan="1" colspan="1">0.08</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
<italic>N</italic> with RT genotype</td>
              <td align="center" rowspan="1" colspan="1">228</td>
              <td align="center" rowspan="1" colspan="1">32</td>
              <td align="center" rowspan="1" colspan="1">51</td>
              <td align="center" rowspan="1" colspan="1">145</td>
              <td align="center" rowspan="1" colspan="1">&#x2013;</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">&#x2003;NRTI</td>
              <td align="center" rowspan="1" colspan="1">6 (2.6)</td>
              <td align="center" rowspan="1" colspan="1">2 (6.3)</td>
              <td align="center" rowspan="1" colspan="1">2 (3.9)</td>
              <td align="center" rowspan="1" colspan="1">2 (1.4)</td>
              <td align="center" rowspan="1" colspan="1">0.09</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">&#x2003;NNRTI</td>
              <td align="center" rowspan="1" colspan="1">5 (2.2)</td>
              <td align="center" rowspan="1" colspan="1">3 (9.4)</td>
              <td align="center" rowspan="1" colspan="1">1 (2.0)</td>
              <td align="center" rowspan="1" colspan="1">1 (0.7)</td>
              <td align="center" rowspan="1" colspan="1">0.01</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
<italic>N</italic> with PR genotype</td>
              <td align="center" rowspan="1" colspan="1">225</td>
              <td align="center" rowspan="1" colspan="1">32</td>
              <td align="center" rowspan="1" colspan="1">50</td>
              <td align="center" rowspan="1" colspan="1">143</td>
              <td align="center" rowspan="1" colspan="1">&#x2013;</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">&#x2003;PI</td>
              <td align="center" rowspan="1" colspan="1">8 (3.6)</td>
              <td align="center" rowspan="1" colspan="1">1 (3.1)</td>
              <td align="center" rowspan="1" colspan="1">3 (6.0)</td>
              <td align="center" rowspan="1" colspan="1">4 (2.8)</td>
              <td align="center" rowspan="1" colspan="1">0.64</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn>
            <p>RT, reverse transcriptase; NRTI, nucleoside/nucleotide reverse transcriptase inhibitor; NNRTI, non-nucleoside reverse transcriptase inhibitor; PR, protease region; PI, protease inhibitor.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>The most common SDRM were K103N and M46I, each found in three participants. The M41L and Y181C mutations were each found in two participants. Three additional subjects had mutations at the E138 codon in the RT gene (E138A in two subjects and E138K in one subject), which confers low-level resistance to the NNRTI class and is included in the IAS-USA list of HIV resistance mutations [<xref rid="CIT0030" ref-type="bibr">30</xref>], but does not appear in the WHO SDRM list. All SDRM detected and a summary of the characteristics of the 16 subjects with SDRM are listed in <xref ref-type="table" rid="T0003">Table 3</xref>.</p>
      <table-wrap id="T0003" position="float">
        <label>Table 3</label>
        <caption>
          <p>Characteristics of acute HIV-positive patients with transmitted drug resistance mutations</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th rowspan="3" valign="bottom" align="left" colspan="1">ID</th>
              <th rowspan="3" valign="bottom" align="center" colspan="1">Date<xref ref-type="table-fn" rid="TF0001">a</xref>
</th>
              <th rowspan="3" valign="bottom" align="center" colspan="1">Age</th>
              <th rowspan="3" valign="bottom" align="center" colspan="1">Risk</th>
              <th rowspan="3" valign="bottom" align="center" colspan="1">Days since HIV exposure</th>
              <th rowspan="3" valign="bottom" align="center" colspan="1">Fiebig stage</th>
              <th rowspan="3" valign="bottom" align="center" colspan="1">4thG stage</th>
              <th rowspan="3" valign="bottom" align="center" colspan="1">HIV RNA<xref ref-type="table-fn" rid="TF0002">b</xref>
</th>
              <th rowspan="3" valign="bottom" align="center" colspan="1">CD4<xref ref-type="table-fn" rid="TF0003">c</xref>
</th>
              <th rowspan="3" valign="bottom" align="center" colspan="1">HIV subtype</th>
              <th align="center" colspan="3" rowspan="1">Resistance mutations</th>
            </tr>
            <tr>
              <th colspan="3" rowspan="1">
<hr/>
</th>
            </tr>
            <tr>
              <th align="center" rowspan="1" colspan="1">NRTI</th>
              <th align="center" rowspan="1" colspan="1">NNRTI</th>
              <th align="center" rowspan="1" colspan="1">PI</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">01</td>
              <td align="center" rowspan="1" colspan="1">05/09</td>
              <td align="center" rowspan="1" colspan="1">28</td>
              <td align="center" rowspan="1" colspan="1">MSM</td>
              <td align="center" rowspan="1" colspan="1">14</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="center" rowspan="1" colspan="1">6.5</td>
              <td align="center" rowspan="1" colspan="1">426</td>
              <td align="center" rowspan="1" colspan="1">CRF01_AE</td>
              <td align="center" rowspan="1" colspan="1">&#x2013;</td>
              <td align="center" rowspan="1" colspan="1">K103N</td>
              <td align="center" rowspan="1" colspan="1">&#x2013;</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">02</td>
              <td align="center" rowspan="1" colspan="1">06/09</td>
              <td align="center" rowspan="1" colspan="1">29</td>
              <td align="center" rowspan="1" colspan="1">MSM</td>
              <td align="center" rowspan="1" colspan="1">20</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="center" rowspan="1" colspan="1">5.5</td>
              <td align="center" rowspan="1" colspan="1">740</td>
              <td align="center" rowspan="1" colspan="1">CRF01_AE</td>
              <td align="center" rowspan="1" colspan="1">&#x2013;</td>
              <td align="center" rowspan="1" colspan="1">K103N</td>
              <td align="center" rowspan="1" colspan="1">&#x2013;</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">03</td>
              <td align="center" rowspan="1" colspan="1">03/10</td>
              <td align="center" rowspan="1" colspan="1">34</td>
              <td align="center" rowspan="1" colspan="1">MSM</td>
              <td align="center" rowspan="1" colspan="1">15</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="center" rowspan="1" colspan="1">5.6</td>
              <td align="center" rowspan="1" colspan="1">386</td>
              <td align="center" rowspan="1" colspan="1">CRF01_AE</td>
              <td align="center" rowspan="1" colspan="1">T215F</td>
              <td align="center" rowspan="1" colspan="1">Y181C</td>
              <td align="center" rowspan="1" colspan="1">M46I</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">04</td>
              <td align="center" rowspan="1" colspan="1">08/10</td>
              <td align="center" rowspan="1" colspan="1">24</td>
              <td align="center" rowspan="1" colspan="1">MSM</td>
              <td align="center" rowspan="1" colspan="1">24</td>
              <td align="center" rowspan="1" colspan="1">5</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="center" rowspan="1" colspan="1">5.5</td>
              <td align="center" rowspan="1" colspan="1">736</td>
              <td align="center" rowspan="1" colspan="1">CRF01_AE</td>
              <td align="center" rowspan="1" colspan="1">M41L</td>
              <td align="center" rowspan="1" colspan="1">&#x2013;</td>
              <td align="center" rowspan="1" colspan="1">&#x2013;</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">05</td>
              <td align="center" rowspan="1" colspan="1">07/11</td>
              <td align="center" rowspan="1" colspan="1">26</td>
              <td align="center" rowspan="1" colspan="1">HF</td>
              <td align="center" rowspan="1" colspan="1">17</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="center" rowspan="1" colspan="1">5.8</td>
              <td align="center" rowspan="1" colspan="1">342</td>
              <td align="center" rowspan="1" colspan="1">CRF01_AE</td>
              <td align="center" rowspan="1" colspan="1">&#x2013;</td>
              <td align="center" rowspan="1" colspan="1">G190A, Y181C</td>
              <td align="center" rowspan="1" colspan="1">&#x2013;</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">06</td>
              <td align="center" rowspan="1" colspan="1">02/12</td>
              <td align="center" rowspan="1" colspan="1">30</td>
              <td align="center" rowspan="1" colspan="1">MSM</td>
              <td align="center" rowspan="1" colspan="1">13</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="center" rowspan="1" colspan="1">7.5</td>
              <td align="center" rowspan="1" colspan="1">295</td>
              <td align="center" rowspan="1" colspan="1">CRF01_AE</td>
              <td align="center" rowspan="1" colspan="1">&#x2013;</td>
              <td align="center" rowspan="1" colspan="1">&#x2013;</td>
              <td align="center" rowspan="1" colspan="1">F53Y</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">07</td>
              <td align="center" rowspan="1" colspan="1">03/12</td>
              <td align="center" rowspan="1" colspan="1">23</td>
              <td align="center" rowspan="1" colspan="1">MSM</td>
              <td align="center" rowspan="1" colspan="1">32</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="center" rowspan="1" colspan="1">5.6</td>
              <td align="center" rowspan="1" colspan="1">506</td>
              <td align="center" rowspan="1" colspan="1">CRF01_AE</td>
              <td align="center" rowspan="1" colspan="1">&#x2013;</td>
              <td align="center" rowspan="1" colspan="1">&#x2013;</td>
              <td align="center" rowspan="1" colspan="1">L23I</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">08</td>
              <td align="center" rowspan="1" colspan="1">11/12</td>
              <td align="center" rowspan="1" colspan="1">34</td>
              <td align="center" rowspan="1" colspan="1">MSM</td>
              <td align="center" rowspan="1" colspan="1">8</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="center" rowspan="1" colspan="1">4.4</td>
              <td align="center" rowspan="1" colspan="1">878</td>
              <td align="center" rowspan="1" colspan="1">CRF01_AE</td>
              <td align="center" rowspan="1" colspan="1">D67N</td>
              <td align="center" rowspan="1" colspan="1">&#x2013;</td>
              <td align="center" rowspan="1" colspan="1">V82A</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">09</td>
              <td align="center" rowspan="1" colspan="1">12/12</td>
              <td align="center" rowspan="1" colspan="1">45</td>
              <td align="center" rowspan="1" colspan="1">MSM</td>
              <td align="center" rowspan="1" colspan="1">19</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="center" rowspan="1" colspan="1">5.6</td>
              <td align="center" rowspan="1" colspan="1">303</td>
              <td align="center" rowspan="1" colspan="1">B</td>
              <td align="center" rowspan="1" colspan="1">T215E</td>
              <td align="center" rowspan="1" colspan="1">&#x2013;</td>
              <td align="center" rowspan="1" colspan="1">&#x2013;</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">10</td>
              <td align="center" rowspan="1" colspan="1">07/13</td>
              <td align="center" rowspan="1" colspan="1">22</td>
              <td align="center" rowspan="1" colspan="1">MSM</td>
              <td align="center" rowspan="1" colspan="1">20</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="center" rowspan="1" colspan="1">3.6</td>
              <td align="center" rowspan="1" colspan="1">519</td>
              <td align="center" rowspan="1" colspan="1">CRF01_AE</td>
              <td align="center" rowspan="1" colspan="1">L74I</td>
              <td align="center" rowspan="1" colspan="1">&#x2013;</td>
              <td align="center" rowspan="1" colspan="1">&#x2013;</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">11</td>
              <td align="center" rowspan="1" colspan="1">08/13</td>
              <td align="center" rowspan="1" colspan="1">20</td>
              <td align="center" rowspan="1" colspan="1">MSM</td>
              <td align="center" rowspan="1" colspan="1">24</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="center" rowspan="1" colspan="1">4.1</td>
              <td align="center" rowspan="1" colspan="1">332</td>
              <td align="center" rowspan="1" colspan="1">CRF01_AE</td>
              <td align="center" rowspan="1" colspan="1">M41L</td>
              <td align="center" rowspan="1" colspan="1">&#x2013;</td>
              <td align="center" rowspan="1" colspan="1">&#x2013;</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">12</td>
              <td align="center" rowspan="1" colspan="1">01/14</td>
              <td align="center" rowspan="1" colspan="1">31</td>
              <td align="center" rowspan="1" colspan="1">MSM</td>
              <td align="center" rowspan="1" colspan="1">15</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="center" rowspan="1" colspan="1">5.5</td>
              <td align="center" rowspan="1" colspan="1">709</td>
              <td align="center" rowspan="1" colspan="1">CRF01_AE/B</td>
              <td align="center" rowspan="1" colspan="1">&#x2013;</td>
              <td align="center" rowspan="1" colspan="1">&#x2013;</td>
              <td align="center" rowspan="1" colspan="1">M46I</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">13</td>
              <td align="center" rowspan="1" colspan="1">06/14</td>
              <td align="center" rowspan="1" colspan="1">43</td>
              <td align="center" rowspan="1" colspan="1">MSM</td>
              <td align="center" rowspan="1" colspan="1">20</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="center" rowspan="1" colspan="1">5.7</td>
              <td align="center" rowspan="1" colspan="1">433</td>
              <td align="center" rowspan="1" colspan="1">CRF01_AE</td>
              <td align="center" rowspan="1" colspan="1">&#x2013;</td>
              <td align="center" rowspan="1" colspan="1">&#x2013;</td>
              <td align="center" rowspan="1" colspan="1">M46I</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">14</td>
              <td align="center" rowspan="1" colspan="1">07/14</td>
              <td align="center" rowspan="1" colspan="1">26</td>
              <td align="center" rowspan="1" colspan="1">MSM</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="center" rowspan="1" colspan="1">5.8</td>
              <td align="center" rowspan="1" colspan="1">602</td>
              <td align="center" rowspan="1" colspan="1">CRF01_AE</td>
              <td align="center" rowspan="1" colspan="1">&#x2013;</td>
              <td align="center" rowspan="1" colspan="1">&#x2013;</td>
              <td align="center" rowspan="1" colspan="1">G73S</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">15</td>
              <td align="center" rowspan="1" colspan="1">11/14</td>
              <td align="center" rowspan="1" colspan="1">19</td>
              <td align="center" rowspan="1" colspan="1">MSM</td>
              <td align="center" rowspan="1" colspan="1">20</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="center" rowspan="1" colspan="1">7.0</td>
              <td align="center" rowspan="1" colspan="1">222</td>
              <td align="center" rowspan="1" colspan="1">CRF01_AE</td>
              <td align="center" rowspan="1" colspan="1">&#x2013;</td>
              <td align="center" rowspan="1" colspan="1">&#x2013;</td>
              <td align="center" rowspan="1" colspan="1">M46L</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">16</td>
              <td align="center" rowspan="1" colspan="1">12/14</td>
              <td align="center" rowspan="1" colspan="1">28</td>
              <td align="center" rowspan="1" colspan="1">MSM</td>
              <td align="center" rowspan="1" colspan="1">26</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="center" rowspan="1" colspan="1">6.4</td>
              <td align="center" rowspan="1" colspan="1">545</td>
              <td align="center" rowspan="1" colspan="1">CRF01_AE</td>
              <td align="center" rowspan="1" colspan="1">&#x2013;</td>
              <td align="center" rowspan="1" colspan="1">K103N</td>
              <td align="center" rowspan="1" colspan="1">&#x2013;</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn>
            <p>MSM: Men who have sex with men; HF: heterosexual female.</p>
          </fn>
          <fn id="TF0001">
            <label>a</label>
            <p>Month/year of study enrolment</p>
          </fn>
          <fn id="TF0002">
            <label>b</label>
            <p>log10 copies/ml</p>
          </fn>
          <fn id="TF0003">
            <label>c</label>
            <p>cells/mm<sup>3</sup></p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>One study participant had TDR to two drug classes (NRTI and PI), and another study participant had TDR to all three drug classes. One pair, subjects 1 and 2, were sexual partners with linked HIV transmission by reported history and an identical resistance mutation on genotype testing. Full-length sequencing showed a 0.1% genetic difference in the two viral genomes, phylogenetically confirming the linked HIV transmission. Using a genetic distance of 1.5% as a cut-off, no other linked transmission pairs were found among participants with TDR.</p>
    </sec>
    <sec sec-type="discussion" id="S0004">
      <title>Discussion</title>
      <p>We observed a declining trend in overall TDR prevalence in this prospective cohort of AHI in Thailand. The change was most evident in resistance to NNRTI, which showed a statistically significant decrease from 9.4 to 0.7% over time. NRTI resistance declined from 6.3 to 1.4%, although the change was not statistically significant, while PI resistance had no discernible trend. The low and declining rate of NNRTI resistance is reassuring, given that the current preferred first-line ART regimens in both the Thai and WHO HIV treatment guidelines contain the NNRTI efavirenz [<xref rid="CIT0022" ref-type="bibr">22</xref>,<xref rid="CIT0031" ref-type="bibr">31</xref>].</p>
      <p>The 4.8% prevalence of TDR in this cohort in 2013 to 2014 was similar to other reports from Thailand, which have found TDR prevalences of less than 5% [<xref rid="CIT0014" ref-type="bibr">14</xref>,<xref rid="CIT0015" ref-type="bibr">15</xref>]. A recent meta-analysis also reported a pooled TDR prevalence of 2.9% from seven low- and middle-income countries in South and Southeast Asia [<xref rid="CIT0013" ref-type="bibr">13</xref>]. Several studies of MSM cohorts in China have reported similar TDR prevalences of 4.6 to 5.3% [<xref rid="CIT0016" ref-type="bibr">16</xref>,<xref rid="CIT0032" ref-type="bibr">32</xref>].</p>
      <p>A few studies have reported that MSM in Asia have higher TDR prevalence than heterosexuals [<xref rid="CIT0033" ref-type="bibr">33</xref>,<xref rid="CIT0034" ref-type="bibr">34</xref>]. However, it remains unknown whether this finding is because of a true difference in TDR between MSM and other transmission risk groups, or if it is an artefact of the evolving HIV epidemiology in Asia. MSM are more likely to be recently infected at the time of HIV diagnosis, and TDR detected in early infection may become undetectable by standard assays over time [<xref rid="CIT0002" ref-type="bibr">2</xref>,<xref rid="CIT0009" ref-type="bibr">9</xref>,<xref rid="CIT0010" ref-type="bibr">10</xref>].</p>
      <p>It is not clear why TDR would be declining over time in this cohort, but changes in ART regimens used in public programmes over time could theoretically contribute to better drug adherence and decreased resistance in treated populations. Consistent with the WHO guidelines and as in many other developing countries, in recent years Thailand has changed the preferred first-line regimen for HIV treatment to drugs that require less frequent dosing, have fewer side effects and are easier tolerated by patients, all characteristics that have been associated with better treatment adherence [<xref rid="CIT0035" ref-type="bibr">35</xref>]. The Thai treatment guidelines prior to 2010 included stavudine, zidovudine and nevirapine in first-line regimens; all of which have significant risk of toxicity and require twice-daily dosing [<xref rid="CIT0022" ref-type="bibr">22</xref>,<xref rid="CIT0036" ref-type="bibr">36</xref>]. The current Thai guidelines recommend tenofovir, efavirenz and lamivudine or emtricitabine as the preferred first-line regimen for all patients, which can be dosed once-daily and has fewer side effects than the older regimens [<xref rid="CIT0036" ref-type="bibr">36</xref>]. Better adherence among people on ART could directly lead to less treatment failure, fewer people with resistance mutations and less TDR in the community.</p>
      <p>The patients in this cohort came from a limited number of sites in Bangkok and Pattaya, Thailand, which may limit the generalizability of the findings to other locations. The small sample size, particularly in the first two years of the cohort, may also affect the accuracy of the TDR prevalence estimate for that time period. In addition, the AHI cohort is predominantly MSM; populations with other risk factors for HIV transmission may have different patterns of TDR.</p>
      <p>The major advantage of this study is that genotype resistance testing was performed very early in HIV infection, a median of 18 days after HIV exposure. Most other studies of TDR enrol patients in the chronic phase of HIV infection, when genotype testing is less sensitive for the detection of drug resistance [<xref rid="CIT0008" ref-type="bibr">8</xref>&#x2013;<xref rid="CIT0010" ref-type="bibr">10</xref>].</p>
    </sec>
    <sec sec-type="conclusions" id="S0005">
      <title>Conclusions</title>
      <p>We found a declining trend in TDR among MSM with recently acquired HIV infection in Thailand, with TDR prevalence of 4.8% in 2013 to 2014. Prevalence below 5% meets the WHO definition of low level TDR, where routine genotype testing for resistance prior to the initiation of first-line ART is not recommended [<xref rid="CIT0019" ref-type="bibr">19</xref>]. However, continued surveillance of TDR should be performed to monitor for any change as ART use expands and the HIV epidemic in Thailand continues to evolve.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgements and funding</title>
      <p>This work was supported by a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense (DOD) and by contributions from the Thai Red Cross AIDS Research Center. Antiretroviral therapy was supported by the Thai Government Pharmaceutical Organization, Gilead, Merck and Pfizer. The views expressed are those of the authors and should not be construed to represent the positions of the participating institutions, the U.S. Army, or the Department of Defense.</p>
      <p>The RV 254/SEARCH 010 Study Group includes the Thai Red Cross AIDS Research Centre: Mark de Souza, Thep Chalermchai, Carlo Secdalan, Nipat Teeratakulpisarn, Ponpen Tantivayakul, James Fletcher, Duanghathai Sutthichom, Somprartthana Rattanamanee, Peeriya Mangu, Putthachard Sangtawan, Somporn Tipsuk, Siriporn Sangthong, Sasiwimol Ubolyam, Apicha Mahanontharit, Tippawan Pankam, Supanit Pattanachaiwit; AFRIMS: Robert J. O&#x2019; Connell, Siriwat Akapirat, Vatcharain Assawadarachai, Alexandra Schuetz, Bessara Nuntapinit, Kultida Poltavee, Nantana Tantibul, Susan Mason, Panadda Sawangsinth; the U.S. Military HIV Research Program: Nelson Michael, Eric Sanders-Buell.</p>
    </ack>
    <sec sec-type="COI-statement">
      <title>Competing interests</title>
      <p>The authors have no competing interests to declare.</p>
    </sec>
    <sec id="S0007">
      <title>Authors' contributions</title>
      <p>DJC, TAC and JA developed the data analysis plan and wrote the manuscript. SS, RT and ST performed the laboratory analyses and contributed to the methods section. SP completed the data analysis and tables. DJC, EK, KB, JI and NP collected clinical data and contributed to the introduction and methods of the manuscript. MR, PP, NP and JA developed the study protocol, supervised all aspects of the study implementation and contributed to the discussion section. All authors have read and approved the final manuscript.</p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="CIT0001">
        <label>1</label>
        <element-citation publication-type="book">
          <collab>National AIDS Committee</collab>
          <source>Thailand ending AIDS: 2014 Thailand AIDS response progress report</source>
          <year>2014</year>
          <publisher-loc>Bangkok</publisher-loc>
          <publisher-name>Ministry of Public Health</publisher-name>
        </element-citation>
      </ref>
      <ref id="CIT0002">
        <label>2</label>
        <element-citation publication-type="book">
          <collab>Thailand Working Group on HIV/AIDS Projection</collab>
          <source>AIDS epidemic model projection for HIV/AIDS in Thailand 2010&#x2013;2030 summary report</source>
          <year>2014</year>
          <publisher-loc>Bangkok</publisher-loc>
          <publisher-name>Bureau of Epidemiology, Department of Disease Control, Ministry of Public Health</publisher-name>
        </element-citation>
      </ref>
      <ref id="CIT0003">
        <label>3</label>
        <element-citation publication-type="book">
          <collab>National AIDS Committee</collab>
          <source>Thailand ending AIDS: Thailand AIDS response progress report 2015</source>
          <year>2015</year>
          <publisher-loc>Bangkok</publisher-loc>
          <publisher-name>Ministry of Public Health</publisher-name>
        </element-citation>
      </ref>
      <ref id="CIT0004">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Griensven</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Varangrat</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wimonsate</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Tanpradech</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kladsawad</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Chemnasiri</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Trends in HIV prevalence, estimated HIV incidence, and risk behavior among men who have sex with men in Bangkok, Thailand, 2003&#x2013;20 07</article-title>
          <source>J Acquir Immune Defic Syndr</source>
          <year>2010</year>
          <volume>53</volume>
          <fpage>234</fpage>
          <lpage>9</lpage>
          <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/QAI.0b013e3181c2fc86">http://dx.doi.org/10.1097/QAI.0b013e3181c2fc86</ext-link></comment>
          <pub-id pub-id-type="pmid">19901844</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0005">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Griensven</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Thienkrua</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>McNicholl</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wimonsate</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Chaikummao</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Chonwattana</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evidence of an explosive epidemic of HIV infection in a cohort of men who have sex with men in Thailand</article-title>
          <source>AIDS</source>
          <year>2013</year>
          <volume>27</volume>
          <issue>5</issue>
          <fpage>825</fpage>
          <lpage>32</lpage>
          <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/QAD.0b013e32835c546e">http://dx.doi.org/10.1097/QAD.0b013e32835c546e</ext-link></comment>
          <pub-id pub-id-type="pmid">23169330</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0006">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Griensven</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Holtz</surname>
              <given-names>TH</given-names>
            </name>
            <name>
              <surname>Thienkrua</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Chonwattana</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Wimonsate</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Chaikummao</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Temporal trends in HIV-1 incidence and risk behaviours in men who have sex with men in Bangkok, Thailand, 2006&#x2013;13: an observational study</article-title>
          <source>Lancet HIV</source>
          <year>2015</year>
          <volume>2</volume>
          <issue>2</issue>
          <fpage>e64</fpage>
          <lpage>70</lpage>
          <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S2352-3018(14)00031-9">http://dx.doi.org/10.1016/S2352-3018(14)00031-9</ext-link></comment>
          <pub-id pub-id-type="pmid">26424462</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0007">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>De Souza</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Phanuphak</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Pinyakorn</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Trichavaroj</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Pattanachaiwit</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Chomchey</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Impact of nucleic acid testing relative to antigen/antibody combination immunoassay on the detection of acute HIV infection</article-title>
          <source>AIDS</source>
          <year>2015</year>
          <volume>29</volume>
          <issue>7</issue>
          <fpage>793</fpage>
          <lpage>800</lpage>
          <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/QAD.0000000000000616">http://dx.doi.org/10.1097/QAD.0000000000000616</ext-link></comment>
          <pub-id pub-id-type="pmid">25985402</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0008">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yanik</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Napravnik</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hurt</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Dennis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Quinlivan</surname>
              <given-names>EB</given-names>
            </name>
            <name>
              <surname>Sebastian</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Prevalence of transmitted antiretroviral drug resistance differs between acutely and chronically HIV-infected patients</article-title>
          <source>J Acquir Immune Defic Syndr</source>
          <year>2012</year>
          <volume>61</volume>
          <issue>2</issue>
          <fpage>258</fpage>
          <lpage>62</lpage>
          <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/QAI.0b013e3182618f05">http://dx.doi.org/10.1097/QAI.0b013e3182618f05</ext-link></comment>
          <pub-id pub-id-type="pmid">22692092</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0009">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jain</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Sucupira</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Bacchetti</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Hartogensis</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Diaz</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Kallas</surname>
              <given-names>EG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Differential persistence of transmitted HIV-1 drug resistance mutation classes</article-title>
          <source>J Infect Dis</source>
          <year>2011</year>
          <volume>203</volume>
          <issue>8</issue>
          <fpage>1174</fpage>
          <lpage>81</lpage>
          <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/infdis/jiq167">http://dx.doi.org/10.1093/infdis/jiq167</ext-link></comment>
          <pub-id pub-id-type="pmid">21451005</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0010">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Castro</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Pillay</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Cane</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Asboe</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Cambiano</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Phillips</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Persistence of HIV-1 transmitted drug resistance mutations</article-title>
          <source>J Infect Dis</source>
          <year>2013</year>
          <volume>208</volume>
          <issue>9</issue>
          <fpage>1459</fpage>
          <lpage>63</lpage>
          <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/infdis/jit345">http://dx.doi.org/10.1093/infdis/jit345</ext-link></comment>
          <pub-id pub-id-type="pmid">23904291</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0011">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baraboutis</surname>
              <given-names>IG</given-names>
            </name>
            <name>
              <surname>Papastamopoulos</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Georgiou</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Skoutelis</surname>
              <given-names>AT</given-names>
            </name>
          </person-group>
          <article-title>Revertant multiresistant HIV in chronically infected drug naive patients: when baseline resistance testing is not enough</article-title>
          <source>Int J STD AIDS</source>
          <year>2007</year>
          <volume>18</volume>
          <issue>10</issue>
          <fpage>722</fpage>
          <lpage>4</lpage>
          <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1258/095646207782193830">http://dx.doi.org/10.1258/095646207782193830</ext-link></comment>
          <pub-id pub-id-type="pmid">17945056</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0012">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Van Laethem</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>De Munter</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Schrooten</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Verbesselt</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Van Ranst</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Van Wijngaerden</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>No response to first-line tenofovir+lamivudine+efavirenz despite optimization according to baseline resistance testing: impact of resistant minority variants on efficacy of low genetic barrier drugs</article-title>
          <source>J Clin Virol</source>
          <year>2007</year>
          <volume>39</volume>
          <issue>1</issue>
          <fpage>43</fpage>
          <lpage>7</lpage>
          <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jcv.2007.02.003">http://dx.doi.org/10.1016/j.jcv.2007.02.003</ext-link></comment>
          <pub-id pub-id-type="pmid">17369083</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0013">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rhee</surname>
              <given-names>S-Y</given-names>
            </name>
            <name>
              <surname>Blanco</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Jordan</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lemey</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Varghese</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis</article-title>
          <source>PLoS Med</source>
          <year>2015</year>
          <volume>12</volume>
          <issue>4</issue>
          <fpage>e1001810</fpage>
          <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pmed.1001810">http://dx.doi.org/10.1371/journal.pmed.1001810</ext-link></comment>
          <pub-id pub-id-type="pmid">25849352</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0014">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sungkanuparph</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pasomsub</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Chantratita</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Surveillance of transmitted HIV drug resistance in antiretroviral-naive patients aged less than 25 Years, in Bangkok, Thailand</article-title>
          <source>J Int Assoc Provid AIDS Care</source>
          <year>2014</year>
          <volume>13</volume>
          <issue>1</issue>
          <fpage>12</fpage>
          <lpage>4</lpage>
          <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1177/2325957413488200">http://dx.doi.org/10.1177/2325957413488200</ext-link></comment>
          <pub-id pub-id-type="pmid">23708678</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0015">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sirivichayakul</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kantor</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>DeLong</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Wongkunya</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mekprasan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ruxrungtham</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Transmitted HIV drug resistance at the Thai Red Cross Anonymous Clinic in Bangkok: results from three consecutive years of annual surveillance</article-title>
          <source>J Antimicrob Chemother</source>
          <year>2015</year>
          <volume>70</volume>
          <issue>4</issue>
          <fpage>1146</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">25525199</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0016">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Xing</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Niu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Liao</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ruan</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>X</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The emergence of HIV-1 primary drug resistance genotypes among treatment-naive men who have sex with men in high-prevalence areas in China</article-title>
          <source>Arch Virol</source>
          <year>2013</year>
          <volume>158</volume>
          <issue>4</issue>
          <fpage>839</fpage>
          <lpage>44</lpage>
          <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00705-012-1557-7">http://dx.doi.org/10.1007/s00705-012-1557-7</ext-link></comment>
          <pub-id pub-id-type="pmid">23224760</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0017">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hattori</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Shiino</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Gatanaga</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mori</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Minami</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Uchida</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Characteristics of transmitted drug-resistant HIV-1 in recently infected treatment-naive patients in Japan</article-title>
          <source>J Acquir Immune Defic Syndr</source>
          <year>2016</year>
          <volume>71</volume>
          <issue>4</issue>
          <fpage>367</fpage>
          <lpage>73</lpage>
          <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/QAI.0000000000000861">http://dx.doi.org/10.1097/QAI.0000000000000861</ext-link></comment>
          <pub-id pub-id-type="pmid">26428230</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0018">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lai</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Fang</surname>
              <given-names>CT</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>LH</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>PY</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Transmitted drug resistance of HIV-1 strains among individuals attending voluntary counselling and testing in Taiwan</article-title>
          <source>J Antimicrob Chemother</source>
          <year>2016</year>
          <volume>71</volume>
          <issue>1</issue>
          <fpage>226</fpage>
          <lpage>34</lpage>
          <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/jac/dkv284">http://dx.doi.org/10.1093/jac/dkv284</ext-link></comment>
          <pub-id pub-id-type="pmid">26404079</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0019">
        <label>19</label>
        <element-citation publication-type="book">
          <collab>WHO</collab>
          <source>World Health Organization global strategy for the surveillance and monitoring of HIV drug resistance: an update</source>
          <year>2012</year>
          <publisher-loc>Geneva</publisher-loc>
          <publisher-name>World Health Organization</publisher-name>
        </element-citation>
      </ref>
      <ref id="CIT0020">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ananworanich</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sirivichayakul</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pinyakorn</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Crowell</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Trichavaroj</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Weerayingyong</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>High prevalence of transmitted drug resistance in acute HIV-infected Thai men who have sex with men</article-title>
          <source>J Acquir Immune Defic Syndr</source>
          <year>2015</year>
          <volume>68</volume>
          <issue>4</issue>
          <fpage>481</fpage>
          <lpage>5</lpage>
          <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/QAI.0000000000000502">http://dx.doi.org/10.1097/QAI.0000000000000502</ext-link></comment>
          <pub-id pub-id-type="pmid">25559593</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0021">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ananworanich</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Fletcher</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Pinyakorn</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>van Griensven</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Vandergeeten</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Schuetz</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A novel acute HIV infection staging system based on 4th generation immunoassay</article-title>
          <source>Retrovirology</source>
          <year>2013</year>
          <volume>10</volume>
          <fpage>56</fpage>
          <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1742-4690-10-56">http://dx.doi.org/10.1186/1742-4690-10-56</ext-link></comment>
          <pub-id pub-id-type="pmid">23718762</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0022">
        <label>22</label>
        <element-citation publication-type="book">
          <collab>Bureau of AIDS, TB and STIs</collab>
          <source>Thailand national HIV treatment and prevention guidelines</source>
          <year>2015</year>
          <publisher-loc>Bangkok</publisher-loc>
          <publisher-name>Ministry of Public Health</publisher-name>
        </element-citation>
      </ref>
      <ref id="CIT0023">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Land</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Cunningham</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Frost</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Katzenstein</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kantor</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>TREAT Asia quality assessment scheme (TAQAS) to standardize the outcome of HIV genotypic resistance testing in a group of Asian laboratories</article-title>
          <source>J Virol Methods</source>
          <year>2009</year>
          <volume>159</volume>
          <issue>2</issue>
          <fpage>185</fpage>
          <lpage>93</lpage>
          <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jviromet.2009.03.016">http://dx.doi.org/10.1016/j.jviromet.2009.03.016</ext-link></comment>
          <pub-id pub-id-type="pmid">19490972</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0024">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rhee</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>Gonzales</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Kantor</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Betts</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Ravela</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Shafer</surname>
              <given-names>RW</given-names>
            </name>
          </person-group>
          <article-title>Human immunodeficiency virus reverse transcriptase and protease sequence database</article-title>
          <source>Nucleic Acids Res</source>
          <year>2003</year>
          <volume>31</volume>
          <issue>1</issue>
          <fpage>298</fpage>
          <lpage>303</lpage>
          <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/nar/gkg100">http://dx.doi.org/10.1093/nar/gkg100</ext-link></comment>
          <pub-id pub-id-type="pmid">12520007</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0025">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shafer</surname>
              <given-names>RW</given-names>
            </name>
          </person-group>
          <article-title>Rationale and uses of a public HIV drug-resistance database</article-title>
          <source>J Infect Dis</source>
          <year>2006</year>
          <volume>194</volume>
          <issue>Suppl 1</issue>
          <fpage>S51</fpage>
          <lpage>8</lpage>
          <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1086/505356">http://dx.doi.org/10.1086/505356</ext-link></comment>
          <pub-id pub-id-type="pmid">16921473</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0026">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bennett</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Camacho</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Otelea</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kuritzkes</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Fleury</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kiuchi</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update</article-title>
          <source>PLoS One</source>
          <year>2009</year>
          <volume>4</volume>
          <issue>3</issue>
          <fpage>e4724</fpage>
          <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0004724">http://dx.doi.org/10.1371/journal.pone.0004724</ext-link></comment>
          <pub-id pub-id-type="pmid">19266092</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0027">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arroyo</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Phanuphak</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Krasaesub</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sirivichayakul</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Assawadarachai</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Poltavee</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>HIV type 1 molecular epidemiology among high-risk clients attending the Thai Red Cross Anonymous Clinic in Bangkok, Thailand</article-title>
          <source>AIDS Res Hum Retroviruses</source>
          <year>2010</year>
          <volume>26</volume>
          <issue>1</issue>
          <fpage>5</fpage>
          <lpage>12</lpage>
          <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1089/aid.2009.0150">http://dx.doi.org/10.1089/aid.2009.0150</ext-link></comment>
          <pub-id pub-id-type="pmid">20055593</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0028">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rhee</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>Kantor</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Katzenstein</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Camacho</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Morris</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Sirivichayakul</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>HIV-1 pol mutation frequency by subtype and treatment experience: extension of the HIVseq program to seven non-B subtypes</article-title>
          <source>AIDS</source>
          <year>2006</year>
          <volume>20</volume>
          <issue>5</issue>
          <fpage>643</fpage>
          <lpage>51</lpage>
          <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/01.aids.0000216363.36786.2b">http://dx.doi.org/10.1097/01.aids.0000216363.36786.2b</ext-link></comment>
          <pub-id pub-id-type="pmid">16514293</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0029">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shafer</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Jung</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Betts</surname>
              <given-names>BJ</given-names>
            </name>
          </person-group>
          <article-title>Human immunodeficiency virus type 1 reverse transcriptase and protease mutation search engine for queries</article-title>
          <source>Nat Med</source>
          <year>2000</year>
          <volume>6</volume>
          <issue>11</issue>
          <fpage>1290</fpage>
          <lpage>2</lpage>
          <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/81407">http://dx.doi.org/10.1038/81407</ext-link></comment>
          <pub-id pub-id-type="pmid">11062545</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0030">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wensing</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Calvez</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Gunthard</surname>
              <given-names>HF</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Paredes</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Pillay</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>2014 Update of the drug resistance mutations in HIV-1</article-title>
          <source>Top Antivir Med</source>
          <year>2014</year>
          <volume>22</volume>
          <issue>3</issue>
          <fpage>642</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="pmid">25101529</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0031">
        <label>31</label>
        <element-citation publication-type="book">
          <collab>World Health Organization</collab>
          <source>Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection</source>
          <year>2013</year>
          <publisher-loc>Geneva</publisher-loc>
          <publisher-name>World Health Organization</publisher-name>
        </element-citation>
      </ref>
      <ref id="CIT0032">
        <label>32</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Zhong</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genetic characterization and transmitted drug resistance of the HIV type 1 epidemic in men who have sex with men in Beijing, China</article-title>
          <source>AIDS Res Hum Retroviruses</source>
          <year>2013</year>
          <volume>29</volume>
          <issue>3</issue>
          <fpage>633</fpage>
          <lpage>7</lpage>
          <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1089/aid.2012.0281">http://dx.doi.org/10.1089/aid.2012.0281</ext-link></comment>
          <pub-id pub-id-type="pmid">23121221</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0033">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Xing</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Liao</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Emerging transmitted HIV drug resistance mutations among HIV infected patients prior to start of first-line ART in multiple sites across China</article-title>
          <source>AIDS Res Hum Retroviruses</source>
          <year>2012</year>
          <volume>28</volume>
          <issue>12</issue>
          <fpage>1637</fpage>
          <lpage>9</lpage>
          <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1089/aid.2012.0164">http://dx.doi.org/10.1089/aid.2012.0164</ext-link></comment>
          <pub-id pub-id-type="pmid">22822770</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0034">
        <label>34</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sohn</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Srikantiah</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Sungkanuparph</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Transmitted HIV drug resistance in Asia</article-title>
          <source>Curr Opin HIV AIDS</source>
          <year>2013</year>
          <volume>8</volume>
          <issue>1</issue>
          <fpage>27</fpage>
          <lpage>33</lpage>
          <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/COH.0b013e32835b804f">http://dx.doi.org/10.1097/COH.0b013e32835b804f</ext-link></comment>
          <pub-id pub-id-type="pmid">23196932</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0035">
        <label>35</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thompson</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Mugavero</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Amico</surname>
              <given-names>KR</given-names>
            </name>
            <name>
              <surname>Cargill</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>LW</given-names>
            </name>
            <name>
              <surname>Gross</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel</article-title>
          <source>Ann Intern Med</source>
          <year>2012</year>
          <volume>156</volume>
          <issue>11</issue>
          <fpage>817</fpage>
          <lpage>33</lpage>
          <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.7326/0003-4819-156-11-201206050-00419">http://dx.doi.org/10.7326/0003-4819-156-11-201206050-00419</ext-link></comment>
          <pub-id pub-id-type="pmid">22393036</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0036">
        <label>36</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sungkanuparph</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Techasathit</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Utaipiboon</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Chasombat</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bhakeecheep</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Leechawengwongs</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Thai national guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 20 10</article-title>
          <source>Asian Biomed</source>
          <year>2010</year>
          <volume>4</volume>
          <issue>4</issue>
          <fpage>515</fpage>
          <lpage>28</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
